Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

UNITED THERAPEUTICS (UTHR) Short-Term Debt repayments: 2014-2025

Historic Short-Term Debt repayments for UNITED THERAPEUTICS (UTHR) over the last 1 years, with Jun 2025 value amounting to $400.0 million.

  • UNITED THERAPEUTICS's Short-Term Debt repayments rose 300.00% to $400.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $700.0 million, marking a year-over-year decrease of 36.36%. This contributed to the annual value of $400.0 million for FY2024, which is 300.00% up from last year.
  • UNITED THERAPEUTICS's Short-Term Debt repayments amounted to $400.0 million in Q2 2025, which was up 300.00% from $100.0 million recorded in Q1 2025.
  • UNITED THERAPEUTICS's 5-year Short-Term Debt repayments high stood at $800.0 million for Q1 2022, and its period low was $100.0 million during Q4 2023.
  • For the 3-year period, UNITED THERAPEUTICS's Short-Term Debt repayments averaged around $142.9 million, with its median value being $100.0 million (2025).
  • Data for UNITED THERAPEUTICS's Short-Term Debt repayments shows a peak YoY spiked of 300.00% (in 2025) over the last 5 years.
  • UNITED THERAPEUTICS's Short-Term Debt repayments (Quarterly) stood at $800.0 million in 2022, then reached $100.0 million in 2023, then remained steady at $100.0 million in 2024, then spiked by 300.00% to $400.0 million in 2025.
  • Its Short-Term Debt repayments was $400.0 million in Q2 2025, compared to $100.0 million in Q1 2025 and $100.0 million in Q4 2024.